Rainbow Children’s Hospital reports 23% revenue growth in Q2 FY27

Rainbow Children’s Medicare Limited has announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company reported a 23.2% year-over-year growth in revenue from operations for Q2 FY27, reaching INR 5,480.2 million. EBITDA also saw a substantial increase. For the half-year ended September 30, 2027, revenue from operations grew by 27.6% year-over-year to INR 10,180.1 million.

Rainbow Children’s Hospital Announces Q2 and H1 FY27 Financial Results

Rainbow Children’s Medicare Limited has released its unaudited financial results for the second quarter (Q2) and the first half-year (H1) ended September 30, 2026 (FY27). The company demonstrated robust financial performance with significant year-over-year growth across key metrics.

Q2 FY27 Performance

For the second quarter of FY27, Revenue from operations increased by 23.2% to INR 5,480.2 million, compared to INR 4,448.0 million in Q2 FY26. Total income grew by 22.8% to INR 5,561.5 million. The company also reported an EBITDA (Post Ind AS 116 & excluding other income) of INR 1,699.8 million, a 14.2% increase from the previous year. Profit for the year stood at INR 838.9 million, a 10.9% rise year-over-year.

H1 FY27 Performance

In the first half of FY27, Revenue from operations surged by 27.6% to INR 10,180.1 million, up from INR 7,977.3 million in H1 FY26. Total income also saw a significant jump of 25.8% to INR 10,388.4 million. The EBITDA (Post Ind AS 116 & excluding other income) for H1 FY27 was INR 3,046.3 million, marking a 20.6% increase. The company’s Profit for the year for H1 FY27 was INR 1,464.3 million, a 13.1% improvement compared to H1 FY26.

Key Financial Highlights (Consolidated)

The consolidated statement of profit and loss shows positive trends in both quarterly and half-yearly periods. Total expenses for Q2 FY27 were INR 4,446.5 million, an increase of 26.8% year-over-year, driven by higher costs in areas like professional fees to doctors and employee benefits. Profit before tax for Q2 FY27 was INR 1,115.0 million, up 8.9% year-over-year. For H1 FY27, Profit before tax increased by 12.5% to INR 1,954.6 million.

The company’s operational KPIs and maturity-wise hospital performance data, presented in detail throughout the document, further support the positive financial outlook. Key developments include steady growth in bed capacity, IP discharges, OP consultations, and deliveries, reflecting the company’s expanding operational footprint and service delivery capabilities.

Source: BSE

Previous Article

Studds Accessories approves Q2 results and grants 1.3 lakh stock options

Next Article

Blue Star wins arbitration appeal in Dubai Court of Appeal